Sodium Fluoride F 18 Injection
Product Images NDC 67939-020

Sodium Fluoride F18 Injection, USP is a sterile, non-pyrogenic diagnostic injection meant for intravenous use only, with a concentration of 10-200 mCi/mL at the End of Synthesis (EOS). It comes in a 30 mL multiple-dose vial and each mL contains 0.37 to 7.4 GBq (10 to 200 mCi) of sodium [18F]fluoride in aqueous 0.9% sodium chloride solution. It is recommended to store it at 25°C (77°F) and use it within 10 hours of EOS. The correct dosage can be calculated from the date and time of calibration. The injection is manufactured by The University of Utah's DBA Cyclotron Radiochemistry Lab at Huntsman Cancer Institute, Salt Lake City, UT. Its half-life is 109.7 min.*

Sodium Fluoride F18 Injection is a radioactive solution used for diagnostic purposes through intravenous administration. It comes in a 30mL multiple-dose vial with a concentration of 10-200 mCi/mL at the end of the synthesis. The solution must be stored at a temperature of 25°C (77°F) with permitted excursions between 15-30°C. The product is sterile, non-pyrogenic, and contains no car-rier added sodium [18F]fluoride. It should be used within 10 hours of end of synthesis and must not be used if it is cloudy or contains particulate matter. The correct dosage must be calculated from the date and time of calibration. The radioactive material must be handled and disposed of with caution. The manufacturer of the product is The University of Utah, and it was produced at the DBA Cyclotron Radiochemistry Lab in Salt Lake City, UT. The half-life of the product is 109.7 minutes.*